Federated Hermes
QTTB icon

Federated Hermes’s Q32 Bio QTTB Stock Holding History

Federated Hermes’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Sell
1,050
-1,223
-54% -$10.2K ﹤0.01% 1822
2026
Q1 		$14.6K Hold
2,273
– – ﹤0.01% 1817
2025
Q4 		$7.55K Sell
2,273
-101
-4% -$285 ﹤0.01% 1858
2025
Q3 		$4.7K Sell
2,374
-78
-3% -$150 ﹤0.01% 1948
2025
Q2 		$3.65K Sell
2,452
-30
-1% -$51 ﹤0.01% 1915
2025
Q1 		$4.09K Buy
2,482
+2,025
+443% +$5.45K ﹤0.01% 1898
2024
Q4 		$1.57K Buy
457
+349
+323% +$11K ﹤0.01% 1997
2024
Q3 		$4.82K Buy
+108
New +$3.97K ﹤0.01% 1862
2023
Q1 		– Sell
-16
Closed -$367 – 2282
2022
Q4 		$367 Buy
16
+5
+45% +$133 ﹤0.01% 2103
2022
Q3 		$1K Buy
+11
New +$449 ﹤0.01% 2094
2022
Q2 		– Sell
-334
Closed -$18K – 2304
2022
Q1 		$18K Sell
334
-219
-40% -$13.6K ﹤0.01% 1833
2021
Q4 		$36K Buy
553
+549
+13,725% +$53.3K ﹤0.01% 1824
2021
Q3 		$1K Sell
4
-23,709
-100% -$3.02M ﹤0.01% 2171
2021
Q2 		$3.1M Buy
+23,713
New +$2.96M 0.01% 969
2019
Q2 		– Sell
-7
Closed -$3K – 2233
2019
Q1 		$3K Hold
7
– – ﹤0.01% 2044
2018
Q4 		$3K Sell
7
-1
-13% -$378 ﹤0.01% 2056
2018
Q3 		$3K Buy
+8
New +$2.72K ﹤0.01% 2121

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes's QTTB Position: Q2 2026 in Review

Federated Hermes reduced its Q32 Bio (QTTB) stake by 54% in Q2 2026, selling an estimated $10.2K and leaving 1,050 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Federated Hermes first reported a position in QTTB in Q3 2018 and has held it in 17 quarters since. The position peaked at $3.1M in Q2 2021. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Federated Hermes held 1,050 shares of Q32 Bio worth $13.4K as of Q2 2026.
  • Federated Hermes sold 1,223 Q32 Bio shares in Q2 2026, an estimated $10.2K.
  • Q32 Bio made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1822 holding.
  • Federated Hermes first reported a position in Q32 Bio in Q3 2018 and has held it in 17 quarters since.
  • Federated Hermes's Q32 Bio position peaked at $3.1M in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.